Search results for "From Annals of Internal Medicine"


 
Results 21 - 30 of about 49 for "From Annals of Internal Medicine".

Heart failure hospitalizations similar with DPP-4 inhibitors and other drug options | ACP Diabetes Monthly

The retrospective cohort study used data on almost 80,000 new saxagliptin users and almost 300,000 new sitagliptin users, gathered through the FDA's Mini-Sentinel program from 2006 to 2013.

May 13, 2016 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

January 10, 2014 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

September 14, 2018 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

Meta-analysis assesses sodium-glucose cotransporter 2 (SGLT2) inhibitors | ACP Diabetes Monthly

Sodium-glucose cotransporter 2 inhibitors appear to be an effective option to lower blood sugars in type 2 diabetes, but there is insufficient evidence on their safety and long-term effects, a recent meta-analysis found.

September 12, 2014 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

December 12, 2014 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

Pioglitazone improved NASH markers in patients with type 2 or prediabetes and NASH | ACP Diabetes Monthly

One hundred one patients with prediabetes or type 2 diabetes and biopsy-proven nonalcoholic steatohepatitis (NASH) were prescribed a hypocaloric diet and randomized to 45 mg of pioglitazone per day or placebo for 18 months. After 18 months,

Undiagnosed diabetes may be less common in U.S. than previously estimated | ACP Diabetes Monthly

The overall prevalence of diabetes (diagnosed and confirmed undiagnosed) increased from 5.5% of the U.S. population in 1988 to 1994 to 10.8% in 2011 to 2014, according to data from the National Health and Nutrition Examination Survey (NHANES).

June 13, 2014 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

Result Page: Prev   1   2   3   4   5   Next